Skip to main content

Together we are beating cancer

Donate now

Oesophageal cancer

Showing 12 out of 111 results
Cancer Research UK logo

In the largest study of its kind, Danish researchers have found that the rates of oesophageal cancer among people with Barrett's oesophagus - a common condition that predisposes to the disease - could be up to four times lower than previous estimates. In the largest study of its kind, Danish researchers have found that the rates of oesophageal cancer among people with Barrett's oesophagus - a common condition that predisposes to the disease - could be up to four times lower than previous estimates.

by In collaboration with PA Media Group | News | 13 October 2011

13 October 2011

Cancer Research UK logo

Cancer Research UK has launched a large multi-centre trial to test a new device for detecting Barrett's oesophagus - a condition that puts sufferers at increased risk of developing cancer of the oesophagus, one of the most deadly cancers. Cancer Research UK has launched a large multi-centre trial to test a new device for detecting Barrett's oesophagus - a condition that puts sufferers at increased risk of developing cancer of the oesophagus, one of the most deadly cancers.

by Cancer Research UK | News | 25 July 2011

25 July 2011

Cancer Research UK logo
  • Science & Technology
  • Health & Medicine

Projects launched to crack the cancer code

CANCER RESEARCH UK today launched two pioneering projects to identify the key genetic faults that are driving oesophageal and prostate cancers, which will transform our understanding of the diseases and pave the way to better and more targeted treatments. CANCER RESEARCH UK today launched two pioneering projects to identify the key genetic faults that are driving oesophageal and prostate cancers, which will transform our understanding of the diseases and pave the way to better and more targeted treatments.

by Cancer Research UK | News | 13 July 2011

13 July 2011

Cancer Research UK logo

Cancer Research Technology, the commercial arm of Cancer Research UK, has signed a license agreement to grant antibody medicines company, Affitech A/S, (NASDAQ OMX: AFFI), exclusive rights to a CRT patent application and relevant know how to develop and use therapeutic antibodies that recognise and block the function of CCR4, a protein found on certain tumours - including early and late stage cervical cancer and oesophageal cancer. Cancer Research Technology, the commercial arm of Cancer Research UK, has signed a license agreement to grant antibody medicines company, Affitech A/S, (NASDAQ OMX: AFFI), exclusive rights to a CRT patent application and relevant know how to develop and use therapeutic antibodies that recognise and block the function of CCR4, a protein found on certain tumours - including early and late stage cervical cancer and oesophageal cancer.

by Cancer Research Technology (CRT) | News | 27 April 2011

27 April 2011

Cancer Research UK logo

Alcohol causes at least 13,000 cases of cancer a year in the UK, according to a new report published in the British Medical Journal today (Friday) Alcohol causes at least 13,000 cases of cancer a year in the UK, according to a new report published in the British Medical Journal today (Friday)

by Cancer Research UK | News | 8 April 2011

8 April 2011

Cancer Research UK logo

People should be warned that cancer is linked to obesity and alcohol, rather than urged to eat more fruit and vegetables to protect against the disease. People should be warned that cancer is linked to obesity and alcohol, rather than urged to eat more fruit and vegetables to protect against the disease.

by British Journal of Cancer | News | 1 December 2010

1 December 2010